Evidence map›Paper›PMID 22365663›Full record

ReviewImmunity2012

Constitutive type I interferon modulates homeostatic balance through tonic signaling.

Daniel J Gough, Nicole L Messina, Christopher J P Clarke, Ricky W Johnstone, David E Levy

Open access · bronzeAbstract readReview
In one paragraph

Review in Immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 314 papers.

0numbers the graph read from it
0cells of the map it votes in
314citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

314 citing papers in PubMed, 446 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Getting on your last nerve: IFNs and resistance to infection.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  9. Article
  10. Article
  11. CD8 T Cell Sensing of Type I Interferon Impacts Anergy.European journal of immunology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

254 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Daniel J GoughNew York University Medical Center, New York, NY 10016, USA.
Nicole L Messina
Christopher J P Clarke
Ricky W Johnstone
David E Levy
Columbia University Irving Medical Center · USPeter MacCallum Cancer Centre · AUUniversity of Melbourne · AU

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
SIGNAL TRANSDUCTION PATHWAY IN IFN INDUCED TRANSCRIPTIONR01AI028900 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEVY, DAVID E · 1990 to 2010
$5.6M
NIAID NIH HHS R01 AI028900NIAID NIH HHS R01AI28900NIAID NIH HHS U54 AI057158NIAID NIH HHS U54AI057158
6 · The paper itself

Abstract

Interferons (IFNs) were discovered as cytokines induced during and protecting from viral infection. They have been documented to play essential roles in numerous physiological processes beyond antiviral and antimicrobial defense, including immunomodulation, cell cycle regulation, cell survival, and cell differentiation. Recent data have also uncovered a potentially darker side to IFN, including roles in inflammatory diseases, such as autoimmunity and diabetes. IFN can have effects in the absence of acute infection, highlighting a physiologic role for constitutive IFN. Type I IFNs are constitutively produced at vanishingly low quantities and yet exert profound effects, mediated in part through modulation of signaling intermediates required for responses to diverse cytokines. We review evidence for a yin-yang of IFN function through its role in modulating crosstalk between multiple cytokines by both feedforward and feedback regulation of common signaling intermediates and postulate a homeostatic role for IFN through tonic signaling in the absence of acute infection.

Indexed as

AnimalsAntineoplastic AgentsAntiviral AgentsAutoimmunityCytokinesFeedback, PhysiologicalHomeostasisHumansInterferon Type IPromoter Regions, GeneticSignal TransductionTranscription FactorsAntineoplastic AgentsAntiviral AgentsCytokinesInterferon Type ITranscription Factors

Identifiers

PMID22365663
PMCPMC3294371
OpenAlexW2065794552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.